Prostate Cancer: New treatment offers hope | Dana-Farber Cancer Institute

A recently FDA-approved treatment, Lutetium-PSMA (LUPsma), provides a new prostate cancer treatment option for patients like Paul. The drug works to identify and deliver a targeted dose of radiation to antigens on the cancer cells. Paul shares his experience with the treatment. Video published 8/19/22